Welcome to Psoriasis Guide
Psoriasis Medication Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
About the National Psoriasis Foundation
from:What is the National Psoriasis Foundation? And what does it do for the people in the USA who suffer from this skin disease known as psoriasis? The National Psoriasis Foundation is actually an organization that helps not only the people of the US, but people from all over the world as well. It is dedicated to find ways to control psoriasis and the different problems it presents. The National Psoriasis Foundation has been around for 35 years, and it has been trying to help improve the lives of people who suffer from different kinds of psoriasis.
The National Psoriasis Foundation is an organization that is funded by the donations of corporations and individuals that are dedicated to help those who need their assistance, like people who are afflicted with psoriatic arthritis or other kinds of psoriasis. Another goal of the National Psoriasis Foundation is to get the information that sufferers of psoriasis need and these include the breakthroughs in treatments, updates on possible cures and other such information that can prove to be very helpful to those who need them.
The National Psoriasis Foundation is also an organization that holds numerous activities for the sufferers of psoriasis to get in touch with the staff and people behind the National Psoriasis Foundation. These activities may include awareness drives, sports activities and other such events that can help foster the spirit of camaraderie and unity among those who know what it is like to have psoriasis, those who care about the people who do have this affliction, and those who want to know more about the illness and what can be done to help sufferers of the disease.
The National Psoriasis Foundation gives out information on almost all the factors that seem to have a bearing on the disease. One of the main causes of concern that the foundation has is the acceptance of the people who suffer the stigma of psoriasis in certain communities. Psoriasis is not a contagious disease, and therefore, people should not fear the individuals who have this disease. With the help of information dissemination, people can easily understand that they have nothing to fear from those who have this rather unsightly and bothersome skin condition.
The information that sufferers and non-sufferers get from the foundation will give you a better understanding of the problem that is psoriasis. You can get information on what current treatments are making great progress in treating the types of psoriasis that are harder to treat, and what other milestones are being reached in the fight against the disease called psoriasis.
Psoriasis Medication Specific links
Psoriasis Medication News
Health: Your Skin May Predict Your Risk For A Heart Attack - CBS Local
 CBS Local | Health: Your Skin May Predict Your Risk For A Heart Attack CBS Local And her skin is clearing up, thanks to weekly injections of the psoriasis drug Enbrel. “I just want to keep it where it is. Hopefully with the medication, with everything, hopefully it will keep it under control,” said Alexandra. |
Newer, more expensive psoriasis drugs only slightly more effective than older ... - Medical Xpress
Newer, more expensive psoriasis drugs only slightly more effective than older ... Medical Xpress More expensive biologic treatments for psoriasis were only marginally more effective than standard treatments, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania. |
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ... - PR Newswire (press release)
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ... PR Newswire (press release) SIMPONI is approved in 52 countries for rheumatologic indications, including the United States where SIMPONI received FDA approval in April 2009 for the treatment of moderately to severely active RA with the medicine methotrexate, active psoriatic ... |
FDA panel favors novel arthritis drug from Pfizer - MiamiHerald.com
 AFP | FDA panel favors novel arthritis drug from Pfizer MiamiHerald.com Humira and rival Enbrel were the 10th and 11th best-selling drugs in the US last year, with combined sales of $7 billion, according to IMS Health. The drugs are also prescribed for psoriasis and other diseases of the immune system. Preview: US panel seen backing Pfizer's arthritis drug hope |
FDA panel backs safety and efficacy of new Pfizer rheumatoid arthritis drug - Washington Post
 USA TODAY | FDA panel backs safety and efficacy of new Pfizer rheumatoid arthritis drug Washington Post Humira and rival Enbrel were the 10th and 11th best-selling drugs in the US last year, with combined sales of $7 billion, according to IMS Health. The drugs are also prescribed for psoriasis and other diseases of the immune system. New rheumatoid arthritis pill tofacitinib backed by FDA panel |